DarioHealth Corp. builds digital health and chronic-condition management solutions that combine self-care apps, coaching, analytics, and connected devices for employers, health plans, and pharmaceutical companies. The company grew out of direct-to-consumer digital health and now sells a broader AI-driven platform through B2B and B2B2C channels, with a growing focus on behavioral health, cardiometabolic care, and medication support.
−162,6 %
56,6 %
−186,6 %
−17,3 %
3.76
3.30
| % | |
|---|---|
| Chronic condition management | 40% Digital programs for diabetes, hypertension, weight management, and related conditions. |
| Behavioral health | 20% Mental health and engagement tools sold to health plans, employers, and members. |
| Employer and payer solutions | 25% Enterprise deployments for self-insured employers, health plans, and benefit administrators. |
| Pharmaceutical partnerships | 10% Patient education, adherence support, and journey analytics for drug makers. |
| Direct-to-consumer digital health | 5% Consumer-facing self-care offerings used as an innovation and testing channel. |
The core buyers are health plans, self-insured employers, benefit administrators, and pharmaceutical companies that...
Buy member-facing digital health and behavioral health programs to improve engagement and outcomes.
Purchase chronic condition and wellness solutions to reduce claims costs and improve productivity.
Use the platform for patient education, adherence support, and journey analytics.
Adopt the platform for employee health programs and cost containment.
Use self-care tools and digital coaching, mainly as a product development and engagement channel.
DarioHealth is headquartered in the United States and generates most of its commercial activity there, including...
Management is pushing the business from a D2C origin toward scaled enterprise distribution through employers, health...
Enterprise and partner channels now drive most revenue and offer larger, repeatable contracts.
Employers and payers want tools that improve outcomes and help manage expensive therapies.
Revenue concentration with a major customer creates downside if that relationship weakens.
The company faces customer concentration risk, since a major customer still represents a meaningful share of revenue...
A major customer still accounts for a meaningful share of revenue and receivables, so loss or underperformance would reduce sales quickly.
The company did not meet one financial covenant and may need waivers, amendments, or an equity cure to avoid worse financing terms.
Some medical devices and hardware components are manufactured in China, making the business vulnerable to trade policy changes and sourcing delays.
Principal executive officers and significant operations are in Israel, so conflict or instability could disrupt operations and execution.
Low share price and extreme volatility can restrict access to capital and increase financing uncertainty.
SYRA · Services-Employment Agencies
Syra Health Corp is a U.S.-based healthcare services company organized around workforce staffing, population health, and behavioral and mental health offerings.
DXCM · Surgical & Medical Instruments & Apparatus
DexCom is a U.S.
GXAI · Services-Prepackaged Software
LLY · Pharmaceutical Preparations
Eli Lilly and Company discovers, develops, manufactures, and markets human pharmaceutical products, with a portfolio anchored by diabetes, obesity, oncology, immunology, and neuroscience medicines.
DH · Services-Prepackaged Software
MWAI · Finance Services
: 28/04/2026